Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Commercial Sponsor
NuCana plc
Scientific Title
A Phase III Open-Label, Multi-Centre, Randomized Study Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Previously Untreated Locally Advanced or Metastatic Biliary Tract Cancer